GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-11 Cr | ₹-47 Cr | ₹24 Cr | ₹12 Cr | ₹-1.44 Cr |
What is the latest Cash Flow from Operating Activities ratio of GENNEX LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-47 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹-1.44 Cr |
How is Cash Flow from Operating Activities of GENNEX LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-47 Cr | Negative | |
| Mar2023 | ₹24 Cr | 98.82 | |
| Mar2022 | ₹12 Cr | Positive | |
| Mar2021 | ₹-1.44 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹260.4 Cr | 0.2% | -8.9% | -16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 0.2% |
-8.9% |
-16.7% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses